Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy
Diseases of the Esophagus · 02.11.2026 · 39 (6)
DOI: 10.1093/dote/doag128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 03.11.2026. Verfasst von J S E Quik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Staging, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Esophagogastric Junction. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Endoscopic ultrasonography with fine-needle aspiration (EUS(-FNA)) is recommended by current guidelines as part of the staging for esophageal and gastro-esophageal junction (GEJ) carcinoma, yet its incremental value over modern 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) remains uncertain. This Lessons Learned article reflects on over a decade of EUS(-FNA) and FDG-PET staging in 402 patients with potentially curable esophageal or GEJ carcinoma at a high-volume tertiary referral center. In 91.3% of patients, EUS(-FNA) did not alter the radiation field as would have been defined by FDG-PET. EUS(-FNA) resulted in an expansion of the radiation field in 4.5% and reduction in 4.2% of patients. Squamous cell carcinoma showed more than two-fold greater likelihood of radiation field modification. Among 193 patients classified as FDG-PET non-suspicious for malignant lymph nodes (LNs), EUS-FNA identified malignant LNs in eight patients (4.1%), which influenced the radiation field. In 5 of 402 patients (1.2%) a malignant LN was detected with EUS-FNA in a station that would not have routinely been resected surgically. In patients planned for neoadjuvant or definitive chemoradiotherapy (CRT), LN staging is of direct therapeutic consequence: underestimation of nodal disease may result in geographic miss, while overestimation leads to unnecessary irradiation. In contrast, in patients treated with perioperative 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) followed by surgical lymphadenectomy, most involved LN stations are routinely addressed surgically, limiting the added value of EUS(-FNA) for treatment planning. Therefore, we view EUS(-FNA) as a selective staging tool in patients planned for neoadjuvant or definitive CRT, rather than a procedure applied routinely to all patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
- Department of Gastrointestinal Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
ORCID-Profile: L L Kodach
Zitieren
APA
Quik, J. S. E., van Sandick, J. W., Owers, E. C., Bartels-Rutten, A., Voncken, F. E. M., Kodach, L. L., de Wijkerslooth, T. R., van Dieren, J. M., & IJspeert, J. E. G. (2026). Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy. Diseases of the Esophagus, 39(6). https://doi.org/10.1093/dote/doag128
Vancouver
Quik JSE, van Sandick JW, Owers EC, Bartels-Rutten A, Voncken FEM, Kodach LL, et al. Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy. Diseases of the Esophagus. 2026;39(6). doi:10.1093/dote/doag128
BibTeX
@article{Quik2026,
author = {Quik, J S E and van Sandick, J W and Owers, E C and Bartels-Rutten, A and Voncken, F E M and Kodach, L L and de Wijkerslooth, T R and van Dieren, J M and IJspeert, J E G},
title = {Lessons learned from a decade of EUS(-FNA) staging in esophageal and GEJ carcinoma: towards a selective staging strategy},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {6},
doi = {10.1093/dote/doag128}
}
EUVIMED